Home > Insider Trading > Filing (0001209191-10-028785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1047699	King Pharmaceuticals Inc	KG	Pharmaceutical Preparations (2834)	541684963

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1031735	L Derace Schaffer	C/O King Pharmaceuticals, Inc. 501 Fifth Street Bristol TN 37620		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-14	16,201	$8.95	19,375	No	4	A	Direct
Common Stock	Acquisiton	2010-05-14	10,000	$8.95	29,375	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Footnotes

Represents an automatic grant of restricted stock units. The director may elect within 20 business days of the grant date to defer receipt of the shares of common stock issuable under the restricted stock units until 6 months after the date the director ceases to be a director. If the director does not defer receipt of the shares, he will be entitled to receive them on the first to occur of: (1) May 14, 2011; and (2) the day which is 6 months after the first to occur of: (a) the director, standing for reelection, not being reelected; and (b) the director completing his term of office after declining to stand for reelection, not being nominated to stand for reelection or having been ineligible to stand for reelection under term limit provisions then in effect. Upon a change of control, as defined in the King Pharmaceuticals, Inc. Incentive Plan, the director will be entitled to receive the shares on the date of the change of control.